Oppenheimer appoints managing director for life sciences research team | S&P Global Market Intelligence

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
In PersonPolitics & Policy: Market Impacts and Mid-Year Outlooks
- 06/24/2022
- Sofitel Washington DC Lafayette Square
- 8:30 AM – 12:00 PM ET
Webinar ReplaysExpand Your Perspective: Analyzing Deal Activity & Drivers Across the Capital Markets
- 06/08/2022
- On-Demand
- 1 Hour
In Person451Nexus
- 10/03/2022
- ARIA Resort and Casino, Las Vegas, Nevada
- ARIA Resort and Casino
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

Oppenheimer appoints managing director for life sciences research team

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Commercial Banking: June 22nd Edition

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Commercial Banking Newsletter June Edition - 2022

26 Feb, 2018 | 16:44

Oppenheimer appoints managing director for life sciences research team

Author Komal Nadeem
Theme Banking

Oppenheimer & Co. Inc. appointed Leland Gershell as managing director and senior analyst on the life sciences research team.

He joined the company from Capricor Therapeutics.

Oppenheimer & Co. Inc. is a subsidiary of Oppenheimer Holdings Inc.

Author
Komal Nadeem
Theme
Banking